EMPA-KIDNEY

Positive predictive value of respiratory infection diagnoses in the Danish National Patient Registry: A post hoc validation analysis of the DANFLU-1 trial

Christensen J. et al, (2026), International Journal of Infectious Diseases, 168

Kidney Function and Mortality in Mexico: Prospective Study of 130,000 Adults

Aguilar-Ramirez D. et al, (2026), Kidney Medicine, 8

Individual Participant Level Meta-Analysis Of The Effects Of Empagliflozin On Conventional And Exploratory Acute And Chronic Kidney Outcomes

Herrington W. et al, (2026), The Lancet Diabetes and Endocrinology

High-Dose vs Standard-Dose Influenza Vaccine in Older Adults With Diabetes: A Secondary Analysis of the DANFLU-2 Randomized Clinical Trial

Nielsen AB. et al, (2026), JAMA Internal Medicine, 186

Assessment of adverse effects attributed to statin therapy in product labels: a meta-analysis of double-blind randomised controlled trials

Reith C. et al, (2026), Lancet, 407, 689 - 703

Relative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccination Against Hospitalizations and Deaths According to Frailty Score: A Post Hoc Analysis of the DANFLU-1 Randomized Trial

Espersen C. et al, (2026), Journal of Infectious Diseases, 233, e89 - e98

Effects of Empagliflozin on Kidney and Cardiac Magnetic Resonance Imaging Measures in Patients With CKD: An EMPA-KIDNEY Mechanistic Substudy

Zhu D. et al, (2026), American Journal of Kidney Diseases

Effects of Sodium Glucose Cotransporter 2 Inhibitors by Diabetes Status and Level of Albuminuria: A Meta-Analysis

Staplin N. et al, (2026), JAMA

Characteristics of Interventional Clinical Trials Registered in ClinicalTrials.gov, 2018-2023

Sullenger RD. et al, (2026), Journal of Clinical and Translational Science

SGLT2 Inhibitors and Kidney Outcomes by Glomerular Filtration Rate and Albuminuria: A Meta-Analysis

Neuen BL. et al, (2026), JAMA

Relative effectiveness of high-dose versus standard-dose influenza vaccine against hospitalizations and mortality according to Charlson Comorbidity Index: A post-hoc analysis of the DANFLU-1 randomized trial

Bernholm KF. et al, (2026), European Journal of Clinical Microbiology and Infectious Diseases

Multinational validation of the PREVENT and SCORE2 cardiovascular risk equations across 6.4 million individuals

Neuen BL. et al, (2026), Nature Medicine

High-Dose Influenza Vaccine Effectiveness against Hospitalization in Older Adults

Johansen ND. et al, (2025), New England Journal of Medicine, 393, 2291 - 2302

Discordance in Creatinine- and Cystatin C-Based eGFR and Clinical Outcomes: A Meta-Analysis

Estrella MM. et al, (2025), JAMA, 334, 1915 - 1926

Large simple randomized controlled trials—from drugs to medical devices: lessons from recent experience

Buccheri S. et al, (2025), Trials, 26

Effects of empagliflozin on conventional and exploratory acute and chronic kidney outcomes: an individual participant-level meta-analysis

Herrington WG. et al, (2025), Lancet Diabetes Endocrinology, 13, 1003 - 1014

Correction to: Large simple randomized controlled trials—from drugs to medical devices: lessons from recent experience (Trials, (2025), 26, 1, (24), 10.1186/s13063-025-08724-x)